相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy
Aline Fernanda Ferreira et al.
ACTA HAEMATOLOGICA (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Immunogenic cell death
Abhishek D. Garg et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2015)
Treatment With Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: Is It Forever?
Beth Overmoyer
JOURNAL OF CLINICAL ONCOLOGY (2015)
Lectins with Potential for Anti-Cancer Therapy
Tammy Yau et al.
MOLECULES (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Jitka Fucikova et al.
FRONTIERS IN IMMUNOLOGY (2015)
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2015)
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study
C. Jackisch et al.
ANNALS OF ONCOLOGY (2015)
Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib
Inger S. Nijhof et al.
CLINICAL CANCER RESEARCH (2015)
Individualized Medicine from Prewomb to Tomb
Eric J. Topol
CELL (2014)
First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer
Laleh Amiri-Kordestani et al.
CLINICAL CANCER RESEARCH (2014)
Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells
Chang-Eui Hong et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Adenovirus Carrying Gene Encoding Haliotis discus discus Sialic Acid Binding Lectin Induces Cancer Cell Apoptosis
Xinyan Yang et al.
MARINE DRUGS (2014)
Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex
Kiyoko Hirano et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cancer-selective induction of apoptosis by leczyme
Takeo Tatsuta et al.
FRONTIERS IN ONCOLOGY (2014)
O-GlcNAc profiling: from proteins to proteomes
Junfeng Ma et al.
CLINICAL PROTEOMICS (2014)
The prognostic value of apoptotic and proliferative markers in breast cancer
Charla C. Engels et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Glycobiology of cell death: when glycans and lectins govern cell fate
R. G. Lichtenstein et al.
CELL DEATH AND DIFFERENTIATION (2013)
Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells
Jee-Eun Kim et al.
PHARMACOLOGICAL RESEARCH (2013)
Regulation of the metastatic cell phenotype by sialylated glycans
Matthew J. Schultz et al.
CANCER AND METASTASIS REVIEWS (2012)
Defining the Benefits of Neoadjuvant Chemotherapy for Breast Cancer
Anne F. Schott et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
Tatiana M. Prowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New insights into the mechanisms of organ-specific breast cancer metastasis
Girieca Lorusso et al.
SEMINARS IN CANCER BIOLOGY (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Tracking N-Acetyllactosamine on Cell-Surface Glycans In Vivo
Tianqing Zheng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
Gerald W. Hart et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
Davide Torti et al.
EMBO MOLECULAR MEDICINE (2011)
Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
Michael. S. van der Veer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines
Timothy M. Clay et al.
IMMUNOLOGIC RESEARCH (2011)
Requirement of the Acquired Immune System in Successful Cancer Chemotherapy With cis-Diamminedichloroplatinum (II) in a Syngeneic Mouse Tumor Transplantation Model
Keisuke Taniguchi et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells
Wei-Jiunn Lee et al.
ONCOLOGY REPORTS (2011)
Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
Junya Kuroda et al.
MOLECULAR CANCER RESEARCH (2010)
Tumour-associated carbohydrate antigens in breast cancer
Aurelie Cazet et al.
BREAST CANCER RESEARCH (2010)
Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulation
Andres Norambuena et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Philippe Autier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Natural antibodies and cancer
H. Peter Vollmers et al.
NEW BIOTECHNOLOGY (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immune surveillance and immunotherapy: Lessons from carbohydrate mimotopes
Anastas Pashov et al.
VACCINE (2009)
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
Assefa Wondimu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
Neoadjuvant chemotherapy for operable breast cancer
J. S. D. Mieog et al.
BRITISH JOURNAL OF SURGERY (2007)
O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1
Hector F. Valenzuela et al.
CANCER RESEARCH (2007)
Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma
Behjatolah Monzavi-Karbassi et al.
VACCINE (2007)
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy
Tateki Yoshino et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Breast cancer: Achievements in adjuvant systemic therapies in the pre-genomic era
Mariantonietta Colozzaa et al.
ONCOLOGIST (2006)
Biological complexity and drug discovery: a practical systems biology approach
EL Berg et al.
IEE PROCEEDINGS SYSTEMS BIOLOGY (2005)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies - Roles of anoikis
W Aixinjueluo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies
B Monzavi-Karbassi et al.
JOURNAL OF IMMUNOLOGY (2005)
New approaches and therapeutics targeting apoptosis in disease
U Fischer et al.
PHARMACOLOGICAL REVIEWS (2005)
The role of IgM antibodies in the recognition and clearance of apoptotic cells
YF Peng et al.
MOLECULAR IMMUNOLOGY (2005)
Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells
S Varambally et al.
INTERNATIONAL IMMUNOLOGY (2004)
Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt
SH Choi et al.
ARCHIVES OF PHARMACAL RESEARCH (2004)
The KEGG resource for deciphering the genome
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway
Y Kashio et al.
JOURNAL OF IMMUNOLOGY (2003)
Priming characteristics of peptide mimotopes of carbohydrate antigens
B Monzavi-Karbassi et al.
VACCINE (2003)
Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53
SY Lyu et al.
ARCHIVES OF PHARMACAL RESEARCH (2002)
Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release
I Kuwabara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
